Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study (vol 30, pg 424, 2024)

被引:0
|
作者
Lin, Yi-Hsuan [1 ,2 ]
Lin, Chia-Hung [1 ,2 ,3 ]
Lin, Yu-Chih [4 ]
Huang, Yu-Yao [5 ]
Tai, An-Shun [6 ]
Fu, Shih-Chen [7 ]
Lin, Sheng-Hsuan [8 ,9 ]
机构
[1] Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Linkou, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan
[3] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Med Nutr Therapy, Linkou, Taiwan
[5] Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou, Taiwan
[6] Natl Cheng Kung Univ, Dept Stat, Tainan, Taiwan
[7] Natl Dong Hwa Univ, Dept Biochem & Mol Med, Hualien, Taiwan
[8] Natl Yang Ming Chiao Tung Univ, Inst Stat, 1001 Univ Rd, Hsinchu 300, Taiwan
[9] Natl Yang Ming Chiao Tung Univ, Inst Data Sci & Engn, Hsinchu, Taiwan
关键词
D O I
10.1016/j.eprac.2024.06.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:898 / 898
页数:1
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study
    Lin, Yi-Hsuan
    Lin, Chia-Hung
    Lin, Yu-Chih
    Huang, Yu-Yao
    Tai, An-Shun
    Fu, Shih-Chen
    Lin, Sheng-Hsuan
    ENDOCRINE PRACTICE, 2024, 30 (05) : 424 - 430
  • [2] Sodium-glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population-based cohort study
    Aloe, Stephanie
    Filliter, Christopher
    Salmasi, Shahrzad
    Igweokpala, Samuel
    Yu, Oriana H. Y.
    Tagalakis, Vicky
    Filion, Kristian B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (09) : 2902 - 2914
  • [3] Use of sodium-glucose cotransporter-2 inhibitors and risk of dementia: A population-based cohort study
    Zhuo, Lin
    Zhang, Baixue
    Yin, Yueqi
    Sun, Yexiang
    Shen, Peng
    Jiang, Zhiqin
    Zhan, Siyan
    Zhao, Houyu
    DIABETES OBESITY & METABOLISM, 2025, 27 (05): : 2430 - 2441
  • [4] Sodium-Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia : A Population-Based Cohort Study
    Hong, Bin
    Bea, Sungho
    Ko, Hwa Yeon
    Kim, Woo Jung
    Cho, Young Min
    Shin, Ju-Young
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (10) : 1319 - 1329
  • [6] New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study
    Cho, Yun Kyung
    Kim, Sehee
    Kim, Myung Jin
    Lee, Woo Je
    Kim, Ye-Jee
    Jung, Chang Hee
    DIABETES & METABOLISM, 2025, 51 (02)
  • [7] The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study
    Siao, Wun-Zhih
    Lin, Tsung-Kun
    Huang, Jing-Yang
    Tsai, Chin-Feng
    Jong, Gwo-Ping
    DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (02):
  • [8] Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study
    Chang, Hao-Chih
    Kuo, Tzu-Ting
    Chen, Yun-Yu
    Lin, Yenn-Jiang
    Chang, Hung-Yu
    Hung, Chung-Lieh
    Chung, Fa-Po
    DIABETES CARE, 2022, 45 (09) : E129 - E130
  • [9] Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
    Eroglu, Talip E.
    Coronel, Ruben
    Souverein, Patrick C.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (04) : 289 - 295
  • [10] Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes A Population-Based Cohort Study
    Fralick, Michael
    Chen, Sarah K.
    Patorno, Elisabetta
    Kim, Seoyoung C.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (03) : 186 - +